Product Image

Bacopa Monniera 50 mg

Swanson Premium Brand

4.6
(404 ratings)
Bacopa 50 mg
Product Image
Score 35.0

This Swanson Bacopa Monniera offers a very low-cost entry point into Bacopa supplementation but provides a dosage significantly below what is typically considered clinically effective, making its overall utility questionable for those seeking tangible results.

Quantity: 90 Capsule(s)Servings size: 1 Capsule(s) (90 servings)
Selected goals:
Other goals:
Brain Health
Mental Focus
Cognitive Support
Stress Relief

Score 35.0

This Swanson Bacopa Monniera offers a very low-cost entry point into Bacopa supplementation but provides a dosage significantly below what is typically considered clinically effective, making its overall utility questionable for those seeking tangible results.

Analysis

Bacopa Monniera is a well-regarded adaptogenic herb known for its potential benefits in cognitive function, memory enhancement, and stress reduction. This Swanson product provides 50mg of a 10:1 extract. While the 10:1 concentration ratio sounds promising for potency, the absolute quantity of the extract is quite low, especially without specifying the percentage of active bacosides. Many clinical trials demonstrating efficacy for Bacopa use dosages ranging from 150mg to 300mg of extracts standardized to 50% bacosides, or significantly higher amounts of non-standardized material. As such, this 50mg dose, even as a 10:1 extract, may be sub-therapeutic for many individuals seeking significant cognitive or stress-relief benefits, despite its attractive price point of $0.06 per serving. Online reviews often highlight the product's affordability, but some users may find its effects subtle or non-existent compared to more potent formulations recommended by nutritionists.

Pros
  • Extremely affordable price per serving, making it accessible for budget-conscious consumers.
  • From a reputable and well-established brand (Swanson), known for quality control.
  • Simple, single-ingredient formula focused solely on Bacopa Monniera.
Cons
  • The 50mg dose of 10:1 extract is likely insufficient for meaningful therapeutic effects compared to research-backed dosages.
  • Lacks explicit standardization to bacosides, which are the primary active compounds, leading to uncertainty about its potency.
  • May lead to perceived ineffectiveness or subtle results due to its low potency compared to alternatives.
Warnings
  • Individuals expecting significant cognitive or stress benefits might be disappointed due to the potentially sub-therapeutic dosage of active compounds.
  • This product may not be suitable for those seeking clinically proven effective doses of Bacopa Monniera.
Report analysis
$5.99($0.06 per serving)
Amazon
$ 0.00
iHerb
$ 5.99
Report prices

Effectiveness for goals

Dosage, timing & forms

Safety & interactions

Ingredients

IngredientAmount per serving
Bacopa monniera leaf 10:1 extract
50 mg
Adults 18–50
Report overview

Categories

As a Bacopa supplement, its primary ingredient is correct, but the extremely low dosage of extract and lack of bacoside standardization compared to more effective Bacopa products on the market significantly limits its overall utility and impact within the Bacopa collection. It falls short when compared to alternatives offering higher, standardized concentrations of the active compounds.

Goals

Bacopa possesses adaptogenic properties that can aid in stress reduction and anxiety relief. However, the low dose in this product suggests it might only offer very mild or negligible stress relief compared to products with clinically studied dosages, which typically provide more pronounced anxiolytic effects.
The low dosage of 50mg of a 10:1 extract, coupled with the absence of bacoside standardization, makes it unlikely to provide the robust brain health benefits, such as memory improvement and neuroprotection, that are commonly observed in studies utilizing higher, standardized doses of Bacopa Monniera.
For enhanced mental focus and attention, a higher and more consistently dosed Bacopa extract is generally required to observe noticeable improvements. This product's low dosage means it may not adequately support sustained mental acuity as effectively as more potent formulations.
Report alternatives